Journal of Pain and Symptom Management
Volume 39, Issue 4 , Pages 768-778 , April 2010

Antipsychotics for Acute and Chronic Pain in Adults

  • Stefan Seidel, MD

      Affiliations

    • Department of Neurology, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationAddress correspondence to: Stefan Seidel, MD, Department of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.
    • ,
  • Martin Aigner, MD

      Affiliations

    • Department of Psychiatry, Medical University of Vienna, Vienna, Austria
    • ,
  • Michael Ossege, MD

      Affiliations

    • Department of Psychiatry, Medical University of Vienna, Vienna, Austria
    • ,
  • Elisabeth Pernicka, M. MPH

      Affiliations

    • Department of Medical Statistics, Medical University of Vienna, Vienna, Austria
    • ,
  • Brigitte Wildner, M

      Affiliations

    • Information Retrieval Office, Austrian Central Library of Medicine, Vienna, Austria
    • ,
  • Thomas Sycha, MD

      Affiliations

    • Department of Neurology, Medical University of Vienna, Vienna, Austria

,Accepted 28 September 2009.

References 

  1. Patt RB, Proper G, Reddy S. The neuroleptics as adjuvant analgesics. J Pain Symptom Manage. 1994;9:446–453
  2. Burduk P, Guzik P, Piechocka M, et al. Comparison of fentanyl and droperidol mixture (neuroleptanalgesia II) with morphine on clinical outcomes in unstable angina patients. Cardiovasc Drugs Ther. 2000;14:259–269
  3. Bloomfield S, Simard-Savoie S, Bernier J, Tetreault L. Comparative analgesic activity of levomepromazine and morphine in patients with chronic pain. Can Med Assoc J. 1964;90:1156–1159
  4. Breitbart W. Psychotropic adjuvant analgesics for pain in cancer and AIDS. Psychooncology. 1998;7:333–345
  5. Khojainova N, Santiago-Palma J, Kornick C, Breitbart W, Gonzales GR. Olanzapine in the management of cancer pain. J Pain Symptom Manage. 2002;23:346–350
  6. Merskey H. Pharmacological approaches other than opioids in chronic non-cancer pain management. Acta Anaesthesiol Scand. 1997;41:187–190
  7. Silberstein SD, Peres MF, Hopkins MM, et al. Olanzapine in the treatment of refractory migraine and chronic daily headache. Headache. 2002;42:515–518
  8. Lu SR, Fuh JL, Juang KD, Wang SJ. Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache. Headache. 2000;40:724–729
  9. Hakkarainen H, Allonen H. Ergotamine vs. metoclopramide vs. their combination in acute migraine attacks. Headache. 1982;22:10–12
  10. Kiser RS, Cohen HM, Freedenfeld RN, Jewell C, Fuchs PN. Olanzapine for the treatment of fibromyalgia symptoms. J Pain Symptom Manage. 2001;22:704–708
  11. Jermyn RT. A nonsurgical approach to low back pain. J Am Osteopath Assoc. 2001;101:S6–11
  12. Feinberg SD. Prescribing analgesics. How to improve function and avoid toxicity when treating chronic pain. Geriatrics. 2000;55:44;49–50, 53
  13. Gobel H, Stadler T. [Treatment of post-herpes zoster pain with tramadol. Results of an open pilot study versus clomipramine with or without levomepromazine], Drugs. 1997;53(Suppl 2):34–39
  14. Lechin F, van der DB, Lechin ME, et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol. 1989;46:960–963
  15. Peschen-Rosin R. [Chronic facial pain from psychiatric point of view—differential diagnosis and therapeutic strategies], Schmerz. 2002;16:395–403
  16. Gomez-Perez FJ, Rull JA, Dies H, et al. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind crossover study. Pain. 1985;23:395–400
  17. Nix WA. [What is certain in pain therapy? The analgesic potency of neuroleptics in the treatment of chronic pain. A metaanalysis], Schmerz. 1998;12:30–38
  18. Seidel S, Aigner M, Ossege M, et al. Antipsychotics for acute and chronic pain in adults. Cochrane Database Syst Rev. 2008;4:CD004844
  19. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996;17:1–12
  20. Friedman BW, Esses D, Solorzano C, et al. A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med. 2008;52:399–406
  21. Callan JE, Kostic MA, Bachrach EA, Rieg TS. Prochlorperazine vs. promethazine for headache treatment in the emergency department: a randomized controlled trial. J Emerg Med. 2008;35:247–253
  22. Johnston B. Relief of mixed anxiety-depression in terminal cancer patients. Effect of thioridazine. N Y State J Med. 1972;72:2315–2317
  23. Davidsen O, Lindeneg O, Walsh M. Analgesic treatment with levomepromazine in acute myocardial infarction. A randomized clinical trial. Acta Med Scand. 1979;205:191–194
  24. Bussone G, Boiardi A, Merati B, et al. [Tiapride in the treatment of chronic headache], Riv Patol Nerv Ment. 1981;101:247–253(author's translation)
  25. Judkins KC, Harmer M. Haloperidol as an adjunct analgesic in the management of postoperative pain. Anaesthesia. 1982;37:1118–1120
  26. Ginsberg F, Bourguignon RP, Smets P, Famaey JP. Tiapride versus glafenine: a double-blind comparative study in the management of acute rheumatic pain. Curr Med Res Opin. 1983;8:562–569
  27. Roux FX, Mallet A, Meresse S. [Prevention of headache following lumbar puncture. A controlled double blind trial of the effectiveness of intravenous tiapride], Sem Hop. 1983;59:319–321
  28. Zitman FG, Linssen AC, Edelbroek PM, Van Kempen GM. Does addition of low-dose flupentixol enhance the analgetic effects of low-dose amitriptyline in somatoform pain disorder?. Pain. 1991;47:25–30
  29. Langemark M, Olesen J. Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache. 1994;34:20–24
  30. Graff-Radford SB, Shaw LR, Naliboff BN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain. 2000;16:188–192
  31. Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study. Headache. 2006;46:781–787
  32. Pertovaara A, Martikainen IK, Hagelberg N, et al. Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain. Eur J Neurosci. 2004;20:1587–1592
  33. Shimizu T, Iwata S, Morioka H, et al. Antinociceptive mechanism of L-DOPA. Pain. 2004;110:246–249
  34. Paalzow GH. L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses. J Pharmacol Exp Ther. 1992;263:470–479
  35. Hill CH, Miner JR, Martel ML. Olanzapine versus droperidol for the treatment of primary headache in the emergency department. Acad Emerg Med. 2008;15(9):806–811

PII: S0885-3924(10)00081-3

doi: 10.1016/j.jpainsymman.2009.09.008

Journal of Pain and Symptom Management
Volume 39, Issue 4 , Pages 768-778 , April 2010

Article Tools

* Image Usage & Resolution